Recent News

• 03.10.2025 - Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to April 11, 2025
• 01.31.2025 - Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025
• 01.22.2025 - Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication

Recent Filings

• 03.10.2025 - EX-99.1 EX-99.1
• 03.10.2025 - 8-K Current report
• 03.05.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 03.03.2025 - 8-K Current report
• 03.03.2025 - 8-K Current report
• 03.03.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 03.03.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.27.2025 - DEF 14A Other definitive proxy statements
• 02.27.2025 - 8-K Current report
• 02.27.2025 - 424B3 Prospectus [Rule 424(b)(3)]